We demonstrate that HMGA1 is not only a ubiquitous marker of aggressive disease but also a key driver of a stem-like, immunosuppressive tumor microenvironment and a novel determinant of resistance to AKT inhibition. This evidence concerns the gene HMGA1 and neoplasm.